BMC Medical's subsidiary Runmai Investment plans to participate in establishing the Bangqinda Rui Fund to layout strategic emerging industries.

BMC Medical (301367.SZ) announced that its wholly-owned subsidiary Hainan Runmai Investment Co., Ltd. (hereinafter referred to as "Runmai Investment") signed a Partnership Agreement for the Zhengzhou Bangqin Dari Angel Entrepreneurship Investment Fund Partnership Enterprise (Limited Partnership) on November 18, 2024 with Shenzhen Qianhai Bangqin Investment Co., Ltd. (hereinafter referred to as "Bangqin Capital"), Dongguan Songshan Lake Attracting No.1 Development Equity Investment Fund Partnership Enterprise (Limited Partnership), Chonghao Technology Co., Ltd., and Liu Mingyu. The target capital commitment of the Zhengzhou Bangqin Dari Angel Entrepreneurship Investment Fund Partnership Enterprise (Limited Partnership) is RMB 500 million, with the initial fundraising amount being RMB 82 million. The company's wholly-owned subsidiary Runmai Investment, as a limited partner, intends to use the company's own funds to subscribe for RMB 20 million in fund shares of the partnership enterprise. The announcement stated that the actual contribution of the partnership enterprise will be invested entirely in national strategic emerging industries, with at least 80% of the investment going to technology-driven, innovative enterprises in the biomedicine, healthcare, and related industries. This investment aims to seize development opportunities in the healthcare sector and further enhance the industry layout of the listed company.